Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment

Background and Purpose. This study aimed to analyze survival, clinical responses, compliance, and adverse effects in locally advanced head and neck cancer (LAHNC) patients treated with split-dose cisplatin-based concurrent chemoradiation therapy (SD-CCRT) or cetuximab with concurrent radiation thera...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hu, Ming-Hung, Wang, Ling-Wei, Lu, Hsueh-Ju, Chu, Pen-Yuan, Tai, Shyh-Kuan, Lee, Tsung-Lun, Chen, Ming-Huang, Yang, Muh-Hwa, Chang, Peter Mu-Hsin
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2014
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109223/
https://ncbi.nlm.nih.gov/pubmed/25110705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/904341
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items